These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 358677)

  • 1. [Animal studies on antibacterial activity of 10 cephalosporins (author's transl)].
    Marre R; Züllich B; Beck H; Sack K
    Zentralbl Bakteriol Orig A; 1978 Jun; 240(4):529-37. PubMed ID: 358677
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibacterial activity of nitrooxyquinoline studied in 2 experimental models of pyelonephritis induced by Escherichia coli in rats].
    Hatala M; Hnátek J; Liska M; Konícková L; Uhlír O; Prát V
    Cas Lek Cesk; 1973; 112(23):722-5. PubMed ID: 4577401
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the hormonal facilitation of experimental Escherichia-coli-pyelonephritis in the rat].
    Loew H; Bronder B; Ritzerfeld W
    Int J Clin Pharmacol; 1973 Jul; 7(4):303-6. PubMed ID: 4580042
    [No Abstract]   [Full Text] [Related]  

  • 4. Investigations on the effectiveness of cefazedone in experimental E. coli pyelonephritis.
    Sack K; Marre R; Freiesleben H; Henkel W
    Arzneimittelforschung; 1979; 29(2a):414-6. PubMed ID: 385009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic activity of cefazedone in experimental pyelonephritis.
    Quante T; Ritzerfeld W
    Arzneimittelforschung; 1979; 29(2a):417-8. PubMed ID: 385010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibacterial effect of cephalexin monohydrate in urinary tract infections].
    Torres J; Guevara I; Hernandez H
    Prensa Med Mex; 1970; ():65-8. PubMed ID: 4931120
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison of antibacterial effect of rifampicin and cephaloridine on a model of E. coli pyelonephritis in rats].
    Prát V; Konícková L; Hatala M
    Arzneimittelforschung; 1970 Apr; 20(4):554-7. PubMed ID: 4911591
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunological defense and virulence of the agent in experimental chronic infection].
    Henkel W; Freiesleben H; Wöhrmann W; Krüger C; Commichau R
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):306-13. PubMed ID: 4154602
    [No Abstract]   [Full Text] [Related]  

  • 9. Cephacetrile: chemotherapy and toxicology in laboratory animals.
    Kradolfer F; Sackmann W; Zak O; Brunner H; Hess R; Konopka EA; Gelzer J
    Arzneimittelforschung; 1974 Sep; 24(9b):1459-62. PubMed ID: 4611440
    [No Abstract]   [Full Text] [Related]  

  • 10. [Humoral and cellular factors of immunological defense against infection exemplified by estrogen-facilitated pyelonephritis in rats].
    Freiesleben H; Sack K; Woermann K; Henkel W
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):314-20. PubMed ID: 4154603
    [No Abstract]   [Full Text] [Related]  

  • 11. [Significance of estrogen-induced pyelonephritis for the in-vivo testing of antibiotics].
    Commichau R; Henkel W; Freiesleben H; Sack K
    Int J Clin Pharmacol; 1974 Jul; 10(1):70-2. PubMed ID: 4603826
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nalidixic acid sensitivity of an E. coli strain in experimental pyelonephritis].
    Hatala M; Ritzerfeld W; Prát V; Konicková L
    Arch Hyg Bakteriol; 1969 Jun; 153(3):254-9. PubMed ID: 4908403
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antibacterial effect of nalidixic acid in experimental acute Escherichia coli pyelonephritis].
    Prát V; Konícková L; Ritzerfeld W; Losse H
    Arztl Forsch; 1968 Feb; 22(2):69-72. PubMed ID: 4876157
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental therapeutic study on hormonally facilitated pyelonephritis in an acute and chronic test].
    Koch HG; Freiesleben H; Henkel W; Commichau R
    Verh Dtsch Ges Inn Med; 1971; 77():1336-9. PubMed ID: 4949696
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on chloramphenicol sensitivity of an E. coli strain in experimental pyelonephritis].
    Hatala M; Ritzerfeld W; Prat V; Konickova L; Losse H
    Arch Hyg Bakteriol; 1968 Apr; 152(2):181-6. PubMed ID: 4884481
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinicolaboratory experience with cephaloridine.
    Daikos GK; Kontomichalou P; Tsekos G
    Antimicrob Agents Chemother (Bethesda); 1965; 5():908-15. PubMed ID: 5327535
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antibacterial effect of two sulfonamide compoundds in acute experimental E. coli-pyelonephritis].
    Konicková L; Prát V; Ritzerfeld W; Losse H
    Arzneimittelforschung; 1969 Oct; 19(10):1717-20. PubMed ID: 4902491
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of antibacterial effect of ampicillin on ascending E. coli pyelonephritis in rats].
    Konícková L; Prát V; Hatala M
    Cesk Farm; 1969 Jun; 18(4):206-8. PubMed ID: 4895577
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical evaluation of cephalexin monohydrate in the treatment of pyelonephritis].
    Hernandez Alvarez G; Mancera Massieu R; Exaire Murad JE
    Prensa Med Mex; 1970; ():75-82. PubMed ID: 4931122
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experience with cephradine injection in urinary tract infections (author's transl)].
    Unno R; Yamamoto Y
    Jpn J Antibiot; 1976 Nov; 29(11):979-84. PubMed ID: 794525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.